NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Q Bio

Q Bio

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://q.bio/

Last Round

Strategic

Jul 18, 2024

Est. Valuation

$140M

Total Funding Raised

$92M

Company Overview

Q Bio is a healthcare technology company that operates a clinical digital twin platform to evaluate patients' medical histories and identify their current and future health risks through whole-body scans and advanced simulations.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

whole-body MRIdigital twinpreventative healthlongitudinal health trackingfull-body scanmedical imagingquantitative biomarkerspreventative medicinelongevity techhealth dashboardprecision medicineAI diagnosticsbiohackingpreventative screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Q Bio Comps

Public and private peers based on sector, stage, and business model.

Q Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Q Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 18, 2024
VC RoundApr 29, 2021
Series BFeb 20, 2020
Series AFeb 1, 2018
SeedNov 2, 2016
Seed
Jan 29, 2016

Key People

Founding team and executive leadership

Jeffrey Brewer

Chief Executive Officer

Executive Team

George Zamanakos

Chief Operating Officer

Executive Team

Q Bio Investors

Notable investors and investment history

Q Bio investors
InvestorRounds
Andreessen HorowitzStrategic, VC Round, Seed, Series A, Series B
SciFi VenturesSeries B, VC Round, Seed, Series A
Khosla VenturesStrategic, Series B, VC Round, Seed, Series A
Pathfinder Venture CapitalStrategic, Series B, VC Round, Seed, Series A
Thirty Five VenturesSeries B, VC Round
Beast VenturesSeries B, VC Round, Seed
Kaiser Foundation HospitalsStrategic, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2021

    Completed a VC Round funding round.

Q Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Q Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Q Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range38
Year Founded2015
Last FundingJul 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.